Table 1

Demographic and clinical characteristics of rheumatoid arthritis and gout synovial tissue immunohistochemistry
Rheumatoid arthritis (n= 15) Gout (n= 12)
Age (years) 56 ± 13 74 ± 17
Sex, female/male 13/3 2/10
Disease duration (years) 10.3 ± 14.4 2.2 ± 3.5
Swollen joint count 7 ± 5 2 ± 3
C-reactive protein (mg/l) 26.6 ± 21.2 18.2 ± 17.75
Disease Activity Score in 28 joints 5.0 ± 1.2 nd
Erythrocyte sedimentation rate (mm/hour) 40.2 ± 30.3 27.7 ± 19.2
IgM-RF (kU/l) 493 ± 1406 nd
Anti-CCP (kAU/ml) 2472 ± 3600 nd
Number taking NSAIDS (positive/negative) 9/15 5/12
Number taking corticosteroids (positive/negative) 0/15 0/12
Number taking DMARDs (positive/negative) 0/15 0/12
Number taking anti-tumor necrosis factor (positive/negative) 0/15 0/12

Data presented as mean ± standard deviation or number. anti-CCP, anti-cyclic citrullinated protein; DMARD, disease-modifying anti-rheumatic drug; IgM-RF, IgM rheumatoid factor; nd, not determined; NSAID, nonsteroidal anti-inflammatory drug.

Ramos et al.

Ramos et al. Arthritis Research & Therapy 2013 15:R209   doi:10.1186/ar4403

Open Data